LifeMD expands pharmacy services with non-sterile compounding capabilities

LifeMD (LFMD) announced the expansion of its state-of-the-art affiliated pharmacy to include advanced non-sterile compounding capabilities for oral and topical medications. This milestone extends LifeMD’s pharmacy growth strategy by enabling its vertically integrated platform to deliver tailored therapies designed to meet evolving patient needs while improving efficiency and reducing reliance on third-party providers. “Every action we take is focused on strengthening LifeMD’s ability to deliver higher-quality, more accessible care to our patients,” said Justin Schreiber, Chairman and CEO of LifeMD. “By expanding our pharmacy with non-sterile compounding, we are not just adding capabilities, we’re building toward a future where every patient’s care is seamless, personalized, and accessible. This advancement complements our core service areas and brings us closer to delivering an unmatched healthcare experience, where convenience, continuity, and innovation come together to provide the kind of care that people want and deserve.”